Objective:To assess the efficacy of pharmacotherapy (citalopram) and cognitive therapy, alone or in combination for the treatment of major depressive disorder.Methods:This study was a randomised controlled clinical trial. We randomly assigned 120 adults with a major depressive disorder to 8-week treatment with either citalopram, cognitive therapy, or both. Major depressive disorder was diagnosed using DSM-IV criteria. Patients were assessed with the Beck Depression Inventory before and after treatment.Results:Statistical analysis showed that cognitive therapy, pharmacotherapy, and combined therapy were effective in the treatment of depression. There was no significant difference between medication and cognitive therapy. Treatment with the cognitive therapy intervention and citalopram combined yielded better responses than treatment with citalopram or cognitive therapy alone.
Objectives The purpose of this study was to investigate the effect of an anger control training program on resilience, hardiness and general health of school girls. Methods This is a quasi-experimental study with pre-test, post-test, follow-up design using control group. The study population consisted of all female students of technical vocational schools in Tehran, Iran (district 13) in 2017. Of these, 60 were selected using a convenience sampling method and randomly divided into two groups of intervention (n=40) and control (n=20) groups. The instruments were State-Trait Anger Expression Inventory-2 (STAXI-2), Connor-Davidson Resilience Scale, Kobasa's Hardiness Scale, 28item General Health Questionnaire (GHQ-28). The anger control training was presented in 12 sessions, one session per week. Collected data were analyzed using repeated measures ANOVA in SPSS v. 24. Results The anger control training program could significantly reduce the amount of anger and increased the levels of resilience, hardiness and general health in the intervention group compared to the control group (P<0.05). Conclusion Psychoeducational interventions such as anger control training can improve the mental health of school girls.
Objectives: This study aimed to assess and compare the mental and personality disorders among people with substance-related disorder. Methods: This cross sectional study was performed from September 2014 to March 2015 in Hamadan city, Iran. The population of this study was all people who referred to the addiction clinics and were consumers of opioids or methamphetamine. Each client was examined in biaxial axis and patients with mental health were studied in the first axis using the SCID test. Also, in the second axis, the personality disorders were evaluated in the patients using the Minnesota multiphasic personality inventory (MMPI) test. Results:All the 103 patients participated in this study were males. The mean age of the patients was 9.13 ± 9.41 years. The results of the MMPI test revealed that schizoid, paranoid, and passive aggressive personality disorders were significantly higher in people with an opioid use disorder compared with the people who taking methamphetamine. However, an antisocial personality disorder in patients taking methamphetamine was more common than in patients who taking opioid. In patients taking opioids, based on the results of the SCID, depression with or without psychotic features, major depressive disorder (MDD) and panic disorder were significantly higher compared with patients taking methamphetamine. Conclusions: The Bipolar mood disorder, panic disorder, paranoid personality disorder, MDD with psychotic features and passive aggressive personality disorder were more prevalent in patient who taking opiate and the antisocial personality disorder, schizoid personality disorder, substance-induced mood disorder and somatoform disorder were more prevalent in patients taking methamphetamine.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.